Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cigna ( (CI) ) has provided an announcement.
On September 4, 2025, Cigna completed a significant financial maneuver by issuing $4.5 billion in senior notes with varying maturity dates and interest rates. The proceeds from this issuance are intended to repay $2 billion in loans used for a strategic investment and support general corporate purposes, potentially impacting the company’s financial flexibility and strategic positioning.
The most recent analyst rating on (CI) stock is a Buy with a $383.00 price target. To see the full list of analyst forecasts on Cigna stock, see the CI Stock Forecast page.
Spark’s Take on CI Stock
According to Spark, TipRanks’ AI Analyst, CI is a Outperform.
Cigna’s overall stock score is driven by strong financial performance and positive earnings call sentiment, despite challenges in cash flow and elevated medical costs. Technical analysis and valuation suggest moderate potential, with strategic growth initiatives in Evernorth providing a positive outlook.
To see Spark’s full report on CI stock, click here.
More about Cigna
Cigna is a global health services company that provides insurance and related services, focusing on health, life, and accident insurance products. It operates in the healthcare industry, offering a range of services aimed at improving health and well-being.
Average Trading Volume: 1,886,867
Technical Sentiment Signal: Hold
Current Market Cap: $80.27B
See more data about CI stock on TipRanks’ Stock Analysis page.